{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T05:24:11Z","timestamp":1785907451068,"version":"3.56.0"},"reference-count":30,"publisher":"Japan Endocrine Society","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2017]]},"DOI":"10.1507\/endocrj.ej17-0083","type":"journal-article","created":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T22:14:16Z","timestamp":1497996856000},"page":"833-842","source":"Crossref","is-referenced-by-count":13,"title":["In the overnight dexamethasone suppression test, 1.0 mg loading is superior to 0.5 mg loading for diagnosing subclinical adrenal Cushing\u2019s syndrome based on plasma dexamethasone levels determined using liquid chromatography-tandem mass spectrometry"],"prefix":"10.1507","volume":"64","author":[{"given":"Yosuke","family":"Sasaki","sequence":"first","affiliation":[{"name":"Division of Metabolism and Endocrinology, Department of Internal Medicine, St. Marianna University School of Medicine Yokohama City Seibu Hospital, Yokohama, Japan"},{"name":"Division of Metabolism and Endocrinology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuyuki","family":"Katabami","sequence":"additional","affiliation":[{"name":"Division of Metabolism and Endocrinology, Department of Internal Medicine, St. Marianna University School of Medicine Yokohama City Seibu Hospital, Yokohama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiko","family":"Asai","sequence":"additional","affiliation":[{"name":"Division of Metabolism and Endocrinology, Department of Internal Medicine, St. Marianna University School of Medicine Yokohama City Seibu Hospital, Yokohama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Fukuda","sequence":"additional","affiliation":[{"name":"Division of Metabolism and Endocrinology, Department of Internal Medicine, St. Marianna University School of Medicine Yokohama City Seibu Hospital, Yokohama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Division of Metabolism and Endocrinology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Di Dalmazi G, Pasquali R, Beuschlein F, Reincke M (2015) Subclinical hypercortisolism: a state, a syndrome, or a disease? <i>Eur J Endocrinol<\/i> 173: M61-71.","DOI":"10.1530\/EJE-15-0272"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Zografos GN, Perysinakis I, Vassilatou E (2014) Subclinical Cushing\u2019s syndrome: current concepts and trends. <i>Hormones (Athens)<\/i> 13: 323-337.","DOI":"10.14310\/horm.2002.1506"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Liddle GW (1960) Tests of pituitary-adrenal suppressibility in the diagnosis of Cushing\u2019s syndrome. <i>J Clin Endocrinol Metab<\/i> 20: 1539-1560.","DOI":"10.1210\/jcem-20-12-1539"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Nugent CA, Nichols T, Tyler FH (1965) Diagnosis of Cushing\u2019s syndrome: Single dose dexamethasone suppression test. <i>Arch Intern Med<\/i> 116: 172-176.","DOI":"10.1001\/archinte.1965.03870020012006"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, <i>et al<\/i>. (2008) The diagnosis of Cushing\u2019s syndrome: an Endocrine Society Clinical Practice Guideline. <i>J Clin Endocrinol Metab<\/i> 93: 1526-1540.","DOI":"10.1210\/jc.2008-0125"},{"key":"6","unstructured":"6. Nawata H, Demura H, Suda T, Takayanagi R (1996) Adrenal preclinical Cushing\u2019s syndrome, Annual report of the Ministry of Health and Welfare \u201cDisorder of Adrenal Hormones\u201d Research Committee, Japan 1995: 223-226 (In Japanese)."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Oki Y, Hashimoto K, Hirata Y, Iwasaki Y, Nigawara T, <i>et al<\/i>. (2009) Development and validation of a 0.5 mg dexamethasone suppression test as an initial screening test for the diagnosis of ACTH-dependent Cushing\u2019s syndrome. <i>Endocr J<\/i> 56: 897-904.","DOI":"10.1507\/endocrj.K09E-194"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Meikle AW (1982) Dexamethasone suppression tests: usefulness of simultaneous measurement of plasma cortisol and dexamethasone. <i>Clin Endocrinol (Oxf)<\/i> 16: 401-408.","DOI":"10.1111\/j.1365-2265.1982.tb00733.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Loew D, Schuster O, Graul EH (1986) Dose-dependent pharmacokinetics of dexamethasone. <i>Eur J Clin Pharmacol<\/i> 30: 225-230.","DOI":"10.1007\/BF00614309"},{"key":"10","unstructured":"10. Huizenga NA, Koper JW, de Lange P, Pols HA, Stolk RP, <i>et al<\/i>. (1998) Interperson variability but intraperson stability of baseline plasma cortisol concentrations, and its relation to feedback sensitivity of the hypothalamo-pituitary-adrenal axis to a low dose of dexamethasone in elderly individuals. <i>J Clin Endocrinol Metab<\/i> 83: 47-54."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Murakami M, Miyachi Y, Nanno M, Yoshimi T (1990) Radioimmunoassay for dexamethasone and its plasma levels after oral administration in patients with liver disease. <i>Folia Endocrinologica Japonica<\/i> 66: 760-769 (In Japanese).","DOI":"10.1507\/endocrine1927.66.8_760"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Djedovic NK, Rainbow SJ (2011) Detection of synthetic glucocorticoids by liquid chromatography-tandem mass spectrometry in patients being investigated for Cushing\u2019s syndrome. <i>Ann Clin Biochem<\/i> 48: 542-549.","DOI":"10.1258\/acb.2011.010250"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Nickelsen T, Lissner W, Sch&ouml;ffling K (1989) The dexamethasone suppression test and long-term contraceptive treatment: measurement of ACTH or salivary cortisol does not improve the reliability of the test. <i>Exp Clin Endocrinol<\/i> 94: 275-280.","DOI":"10.1055\/s-0029-1210910"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. <i>Clin Chem<\/i> 18: 499-502.","DOI":"10.1093\/clinchem\/18.6.499"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Arnaldi G, Scandali VM, Trementino L, Cardinaletti M, Appolloni G, <i>et al<\/i>. (2010) Pathophysiology of dyslipidemia in Cushing\u2019s Syndrome. <i>Neuroendocrinology<\/i> 92: 86-90.","DOI":"10.1159\/000314213"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Akehi Y, Kawate H, Murase K, Nagaishi R, Nomiyama T, <i>et al<\/i>. (2013) Proposed diagnostic criteria for subclinical Cushing\u2019s syndrome associated with adrenal incidentaloma. <i>Endocr J<\/i> 60: 903-912.","DOI":"10.1507\/endocrj.EJ12-0458"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Wooding KM, Auchus RJ (2013) Mass spectrometry theory and application to adrenal diseases. <i>Mol Cell Endocrinol<\/i> 371: 201-207.","DOI":"10.1016\/j.mce.2012.12.026"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Methlie P, Hustad SS, Kellmann R, Alm&aring;s B, Erichsen MM, <i>et al<\/i>. (2013) Multisteroid LC-MS\/MS assay for glucocorticoids and androgens, and its application in Addison\u2019s disease. <i>Endocr Connect<\/i> 2: 125-136.","DOI":"10.1530\/EC-13-0023"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Kanazu T, Sato N, Kadono K, Touchi A, Takeda Y, <i>et al<\/i>. (2012) Investigation of drug-drug interaction via mechanism-based inhibition of cytochrome P450 3A by macrolides in dexamethasone-treated female rats. <i>Biopharm Drug Dispos<\/i> 33: 195-206.","DOI":"10.1002\/bdd.1785"},{"key":"20","unstructured":"20. Kyriazopoulou V, Vagenakis AG (1992) Abnormal overnight dexamethasone suppression test in subjects receiving rifampicin therapy. <i>J Clin Endocrinol Metab<\/i> 75: 315-317."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Hempen C, Elfering S, Mulder AH, van den Bergh FA, Maatman RG (2012) Dexamethasone suppression test: development of a method for simultaneous determination of cortisol and dexamethasone in human plasma by liquid chromatography\/tandem mass spectrometry. <i>Ann Clin Biochem<\/i> 49: 170-176.","DOI":"10.1258\/acb.2011.011004"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Ray JA, Kushnir MM, Rockwood AL, Meikle AW (2011) Analysis of cortisol, cortisone and dexamethasone in human serum using liquid chromatography tandem mass spectrometry and assessment of cortisol: Cortisone ratios in patients with impaired kidney function. <i>Clin Chim Acta<\/i> 412: 1221-1228.","DOI":"10.1016\/j.cca.2011.03.016"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. &Aring;svold BO, Grill V, Thorstensen K, Bj&oslash;rgaas MR (2012) Association between posttest dexamethasone and cortisol concentrations in the 1 mg overnight dexamethasone suppression test. <i>Endocr Connect<\/i> 1: 62-67.","DOI":"10.1530\/EC-12-0047"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Pecori Giraldi F, Pivonello R, Ambrogio AG, De Martino MC, De Martin M, <i>et al<\/i>. (2007) The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing\u2019s syndrome from pseudo-Cushing\u2019s states. <i>Clin Endocrinol (Oxf)<\/i> 66: 251-257.","DOI":"10.1111\/j.1365-2265.2006.02717.x"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Morris H, Carr V, Gilliland J, Hooper M (1986) Dexamethasone concentrations and the dexamethasone suppression test in psychiatric disorders. <i>Br J Psychiatry<\/i> 148: 66-69.","DOI":"10.1192\/bjp.148.1.66"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. O\u2019Sullivan BT, Cutler DJ, Hunt GE, Walters C, Johnson GF, <i>et al<\/i>. (1997) Pharmacokinetics of dexamethasone and its relationship to dexamethasone suppression test outcome in depressed patients and healthy control subjects. <i>Biol Psychiatry<\/i> 41: 574-584.","DOI":"10.1016\/S0006-3223(96)00094-7"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Weiner MF (1989) Age and cortisol suppression by dexamethasone in normal subjects. <i>J Psychiatr Res<\/i> 23: 163-168.","DOI":"10.1016\/0022-3956(89)90007-1"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Rockall AG, Sohaib SA, Evans D, Kaltsas G, Isidori AM, <i>et al<\/i>. (2003) Hepatic steatosis in Cushing\u2019s syndrome: a radiological assessment using computed tomography. <i>Eur J Endocrinol<\/i> 149: 543-548.","DOI":"10.1530\/eje.0.1490543"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Woolsey SJ, Mansell SE, Kim RB, Tirona RG, Beaton MD (2015) CYP3A Activity and Expression in Nonalcoholic Fatty Liver Disease. <i>Drug Metab Dispos<\/i> 43: 1484-1490.","DOI":"10.1124\/dmd.115.065979"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Tarantino G, Finelli C (2013) Pathogenesis of hepatic steatosis: The link between hypercortisolism and non-alcoholic fatty liver disease. <i>World J Gastroenterol<\/i> 19: 6735-6743.","DOI":"10.3748\/wjg.v19.i40.6735"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/64\/9\/64_EJ17-0083\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,10]],"date-time":"2020-10-10T14:21:25Z","timestamp":1602339685000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/64\/9\/64_EJ17-0083\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej17-0083","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}